These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9578167)

  • 1. Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens.
    Goldstein EJ; Citron DM; Hudspeth M; Hunt Gerardo S; Merriam CV
    J Antimicrob Chemother; 1998 Mar; 41(3):391-6. PubMed ID: 9578167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans.
    Goldstein EJ; Citron DM; Hudspeth M; Hunt Gerardo S; Merriam CV
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1552-7. PubMed ID: 9210683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates.
    Goldstein EJ; Nesbit CA; Citron DM
    Antimicrob Agents Chemother; 1995 May; 39(5):1097-100. PubMed ID: 7625795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans.
    Goldstein EJ; Citron DM; Hunt Gerardo S; Hudspeth M; Merriam CV
    Antimicrob Agents Chemother; 1998 May; 42(5):1127-32. PubMed ID: 9593139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolates.
    Goldstein EJ; Citron DM; Hunt Gerardo S; Hudspeth M; Merriam CV
    Antimicrob Agents Chemother; 1997 May; 41(5):1193-5. PubMed ID: 9145900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents.
    Goldstein EJ; Citron DM
    Antimicrob Agents Chemother; 1993 May; 37(5):1150-3. PubMed ID: 8390810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell K; Fernandez H
    J Antimicrob Chemother; 2001 Nov; 48(5):641-51. PubMed ID: 11679553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid activity compared to those of selected macrolides and other agents against aerobic and anaerobic pathogens isolated from soft tissue bite infections in humans.
    Goldstein EJ; Citron DM; Merriam CV
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1469-74. PubMed ID: 10348773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections.
    Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2525-9. PubMed ID: 10952607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of gatifloxacin compared to those of five other quinolones versus aerobic and anaerobic isolates from skin and soft tissue samples of human and animal bite wound infections.
    Goldstein EJ; Citron DM; Merriam CV; Tyrrell K; Warren Y
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1475-9. PubMed ID: 10348774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group.
    Talan DA; Citron DM; Abrahamian FM; Moran GJ; Goldstein EJ
    N Engl J Med; 1999 Jan; 340(2):85-92. PubMed ID: 9887159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of anaerobic bacteria in bite-wound infections.
    Goldstein EJ; Citron DM; Finegold SM
    Rev Infect Dis; 1984; 6 Suppl 1():S177-83. PubMed ID: 6372026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media.
    Hecht DW; Osmolski JR
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S44-50. PubMed ID: 8953106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest.
    Dembry LM; Farrel PA; Orcutt DR; Gerrity LA; Andriole VT
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():35-42. PubMed ID: 9222068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    J Antimicrob Chemother; 2002 Sep; 50(3):411-20. PubMed ID: 12205068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of gemifloxacin (SB 265805) against anaerobes.
    Goldstein EJ; Citron DM; Warren Y; Tyrrell K; Merriam CV
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2231-5. PubMed ID: 10471570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of gemifloxacin (SB 265805, LB20304) compared to those of other oral antimicrobial agents against unusual anaerobes.
    Goldstein EJ; Citron DM; Vreni Merriam C; Tyrrell K; Warren Y
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2726-30. PubMed ID: 10543754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activities of GAR-936 against aerobic and anaerobic animal and human bite wound pathogens.
    Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2747-51. PubMed ID: 10991855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of anaerobes to quinolones in the United States.
    Hecht DW; Wexler HM
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S2-8. PubMed ID: 8953099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiology of human and animal bite wounds in children.
    Brook I
    Pediatr Infect Dis J; 1987 Jan; 6(1):29-32. PubMed ID: 3822614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.